Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01890486 · ClinicalTrials.gov registry record
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
A clinical trial of Multiple Myeloma and Myelodysplastic Syndromes, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT01890486: Recruiting study of Multiple Myeloma and Myelodysplastic Syndromes, sponsored by Wake Forest University Health Sciences.
NCT01890486 is a study of Multiple Myeloma and Myelodysplastic Syndromes that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 2,000 participants, above the 542-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (269% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01890486, a study of Multiple Myeloma and Myelodysplastic Syndromes, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
To provide the IRB approved mechanism for the prospective collection and analysis on participants who are undergoing either an autologous or allogeneic hematopoietic stem cell transplant for a disease in which a research question is not being addressed.
Primary Outcome
Gather basic survival and complication data for operational and research databases for ongoing regulatory and future operational queries
Conditions Studied
Study Locations (1)
North Carolina
- Wake Forest Baptist Health - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2001-05-21 |
| Est. Completion | 2026-06 |
What NCT01890486 shows while recruiting
NCT01890486 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, above the 542-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (269% higher).
The record links to 10 conditions, with Multiple Myeloma appearing as the primary indexed condition, and to 0 interventions.
NCT01890486 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT01890486 about?
NCT01890486 is a clinical study titled "The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen". To provide the IRB approved mechanism for the prospective collection and analysis on participants who are undergoing either an autologous or allogeneic hematopoietic stem cell transplant for a disease in which a research question is not being addressed.
What is the current status of trial NCT01890486?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2001-05-21. Estimated completion is 2026-06.
What conditions does trial NCT01890486 study?
This clinical trial studies the following conditions: Multiple Myeloma, Myelodysplastic Syndromes, Chronic Lymphocytic Leukemia, Non-Hodgkin's Lymphoma, Acute Myelogenous Leukemia.
Who is sponsoring clinical trial NCT01890486?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01890486 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Myeloma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01890486's enrollment target sits among peer trials
2,000 12th of 438 higher than 426 of 438 other Multiple Myeloma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Multiple Myeloma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
A Study of Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant
RECRUITING · Phase 2
-
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
RECRUITING · Phase 1
-
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
RECRUITING · NA
-
Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities
RECRUITING
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI